| References |
Top |
| REF 1 |
Somatic mutations lead to an oncogenic deletion of met in lung cancer. Cancer Res. 2006 Jan 1;66(1):283-9.
|
| REF 2 |
Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates. EMBO J. 2008 Mar 5;27(5):804-16.
|
| REF 3 |
Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage. Cell Signal. 2009 Sep;21(9):1455-63.
|
| REF 4 |
Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol. 2009 May 18;185(4):743-54.
|
| REF 5 |
An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding. FEBS Lett. 2011 Jan 21;585(2):281-5.
|
| REF 6 |
Signaling by HGF and KGF in corneal epithelial cells: Ras/MAP kinase and Jak-STAT pathways. Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1329-38.
|
| REF 7 |
Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility. J Biol Chem. 1996 Jun 14;271(24):14119-23.
|
| REF 8 |
Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. EXS. 1993;65:131-65.
|
